Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
CLRBZ was delisted on the 16th of April, 2021.
3 hedge funds and large institutions have $1.23M invested in Cellectar Biosciences, Inc. Series A Warrants in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
30,750% more capital invested
Capital invested by funds: $4K → $1.23M (+$1.23M)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more funds holding
Funds holding: 2 → 3 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.84K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$2.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
AIGH Capital Management
Baltimore,
Maryland
| $1.23M | +$84.8K | +583,037 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $4K | +$3.84K | +26,405 | +821% |
|
|
TSS
3
Two Sigma Securities
New York
| $2K | +$2.07K | +14,221 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$4K | -30,498 | Closed |
|
CLRBZ Hedge Fund Activity: Q4 2020 in Review
3 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) for Q4 2020, worth a combined $1.23M — up 30,750% from $4K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CLRBZ positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $3.84K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $4K sold.
- 3 institutional investors held Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) as of Q4 2020, up from 2 in Q3 2020.
- Funds reported $1.23M of Cellectar Biosciences, Inc. Series A Warrants stock for Q4 2020, up 30,750% quarter-over-quarter.
- 2 funds opened new Cellectar Biosciences, Inc. Series A Warrants positions in Q4 2020 and 1 closed out, a net change of +1 holder.
- The largest Cellectar Biosciences, Inc. Series A Warrants buyer in Q4 2020 was UBS Group, an estimated $3.84K added.
- The largest Cellectar Biosciences, Inc. Series A Warrants seller in Q4 2020 was Susquehanna International Group, an estimated $4K sold.
Based on aggregated 13F filings for Q4 2020.